Search research articles
Contact Us
Filters
Showing results (351-360 of 415) with videos related to
Page
of 42
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1986
Effects of N-linked carbohydrate on the in vivo properties of human GM-CSF
R E Donahue, E A Wang, R J Kaufman, et al.
Brain Research
|
May 4, 2026
uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology
Lauren E Sarko, Ella Klaus, Viktoriya Bondarenko, et al.
Diabetes & Metabolism
|
May 1, 2018
Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study
B Balkau, M Metzger, F Andreelli, et al.
The Journal of Clinical Investigation
|
February 13, 2001
In vivo acceleration of heart relaxation performance by parvalbumin gene delivery
M L Szatkowski, M V Westfall, C A Gomez, et al.
Physiological Genomics
|
March 13, 2008
Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action
Sharlene M Day, Pierre Coutu, Wang Wang, et al.
Pharmacology Research & Perspectives
|
March 16, 2016
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target
Wendy Ankrom, Harold B Wood, Jiayi Xu, et al.
Journal of Medicinal Chemistry
|
April 26, 1996
2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist
J J Hale, S G Mills, M MacCoss, et al.
Molecular Psychiatry
|
July 1, 1996
Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree
L Shihabuddin, J M Silverman, M S Buchsbaum, et al.
Endocrinology
|
May 19, 2011
Effects of peripherally administered neuromedin U on energy and glucose homeostasis
Andrea M Peier, Kunal Desai, James Hubert, et al.
Oral Diseases
|
April 9, 2010
Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands
C Zheng, A Voutetakis, M Metzger, et al.
Page
of 42
Search research articles
Search
Showing results (351-360 of 415) with videos related to
Sort By:
Page
of 42
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1986
Effects of N-linked carbohydrate on the in vivo properties of human GM-CSF
R E Donahue, E A Wang, R J Kaufman, et al.
Brain Research
|
May 4, 2026
uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology
Lauren E Sarko, Ella Klaus, Viktoriya Bondarenko, et al.
Diabetes & Metabolism
|
May 1, 2018
Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study
B Balkau, M Metzger, F Andreelli, et al.
The Journal of Clinical Investigation
|
February 13, 2001
In vivo acceleration of heart relaxation performance by parvalbumin gene delivery
M L Szatkowski, M V Westfall, C A Gomez, et al.
Physiological Genomics
|
March 13, 2008
Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action
Sharlene M Day, Pierre Coutu, Wang Wang, et al.
Pharmacology Research & Perspectives
|
March 16, 2016
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target
Wendy Ankrom, Harold B Wood, Jiayi Xu, et al.
Journal of Medicinal Chemistry
|
April 26, 1996
2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist
J J Hale, S G Mills, M MacCoss, et al.
Molecular Psychiatry
|
July 1, 1996
Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree
L Shihabuddin, J M Silverman, M S Buchsbaum, et al.
Endocrinology
|
May 19, 2011
Effects of peripherally administered neuromedin U on energy and glucose homeostasis
Andrea M Peier, Kunal Desai, James Hubert, et al.
Oral Diseases
|
April 9, 2010
Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands
C Zheng, A Voutetakis, M Metzger, et al.
Page
of 42